115 related articles for article (PubMed ID: 7478833)
21. Neonatal Ventilation With Inhaled Nitric Oxide Versus Ventilatory Support Without Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339).
Field D; Elbourne D; Truesdale A; Grieve R; Hardy P; Fenton AC; Subhedar N; Ahluwalia J; Halliday HL; Stocks J; Tomlin K; Normand C;
Pediatrics; 2005 Apr; 115(4):926-36. PubMed ID: 15805366
[TBL] [Abstract][Full Text] [Related]
22. Neurodevelopmental outcome after neonatal extracorporeal membrane oxygenation.
Robertson CM; Finer NN; Sauve RS; Whitfield MF; Belgaumkar TK; Synnes AR; Grace MG
CMAJ; 1995 Jun; 152(12):1981-8. PubMed ID: 7540105
[TBL] [Abstract][Full Text] [Related]
23. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease.
Lodygensky GA; Rademaker K; Zimine S; Gex-Fabry M; Lieftink AF; Lazeyras F; Groenendaal F; de Vries LS; Huppi PS
Pediatrics; 2005 Jul; 116(1):1-7. PubMed ID: 15995023
[TBL] [Abstract][Full Text] [Related]
24. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial.
Durand M; Sardesai S; McEvoy C
Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity.
Odd DE; Armstrong DL; Teele RL; Kuschel CA; Harding JE
J Paediatr Child Health; 2004; 40(5-6):282-9. PubMed ID: 15151582
[TBL] [Abstract][Full Text] [Related]
26. Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group.
Wald ER; Kaplan SL; Mason EO; Sabo D; Ross L; Arditi M; Wiedermann BL; Barson W; Kim KS; Yogov R
Pediatrics; 1995 Jan; 95(1):21-8. PubMed ID: 7770303
[TBL] [Abstract][Full Text] [Related]
27. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP
Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
[TBL] [Abstract][Full Text] [Related]
28. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids.
Crowther CA; Doyle LW; Haslam RR; Hiller JE; Harding JE; Robinson JS;
N Engl J Med; 2007 Sep; 357(12):1179-89. PubMed ID: 17881750
[TBL] [Abstract][Full Text] [Related]
29. A three year follow up of preterm infants after moderately early treatment with dexamethasone.
Romagnoli C; Zecca E; Luciano R; Torrioli G; Tortorolo G
Arch Dis Child Fetal Neonatal Ed; 2002 Jul; 87(1):F55-8. PubMed ID: 12091294
[TBL] [Abstract][Full Text] [Related]
30. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy.
Shinwell ES; Karplus M; Reich D; Weintraub Z; Blazer S; Bader D; Yurman S; Dolfin T; Kogan A; Dollberg S; Arbel E; Goldberg M; Gur I; Naor N; Sirota L; Mogilner S; Zaritsky A; Barak M; Gottfried E
Arch Dis Child Fetal Neonatal Ed; 2000 Nov; 83(3):F177-81. PubMed ID: 11040164
[TBL] [Abstract][Full Text] [Related]
31. Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up.
Romagnoli C; Zecca E; Luciano R; Torrioli G; Tortorolo G
Pediatrics; 2002 Jun; 109(6):e85. PubMed ID: 12042579
[TBL] [Abstract][Full Text] [Related]
32. Neurodevelopmental and respiratory follow-up results at 7 years for children from the United Kingdom and Ireland enrolled in a randomized trial of early and late postnatal corticosteroid treatment, systemic and inhaled (the Open Study of Early Corticosteroid Treatment).
Wilson TT; Waters L; Patterson CC; McCusker CG; Rooney NM; Marlow N; Halliday HL
Pediatrics; 2006 Jun; 117(6):2196-205. PubMed ID: 16740865
[TBL] [Abstract][Full Text] [Related]
33. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease.
Murphy BP; Inder TE; Huppi PS; Warfield S; Zientara GP; Kikinis R; Jolesz FA; Volpe JJ
Pediatrics; 2001 Feb; 107(2):217-21. PubMed ID: 11158449
[TBL] [Abstract][Full Text] [Related]
34. Follow up of a randomised trial of two different courses of dexamethasone for preterm babies at risk of chronic lung disease.
Armstrong DL; Penrice J; Bloomfield FH; Knight DB; Dezoete JA; Harding JE
Arch Dis Child Fetal Neonatal Ed; 2002 Mar; 86(2):F102-7. PubMed ID: 11882552
[TBL] [Abstract][Full Text] [Related]
35. Early life intervention with glucocorticoids has negative effects on motor development and neuropsychological function in 14-17 year-old adolescents.
ter Wolbeek M; de Sonneville LM; de Vries WB; Kavelaars A; Veen S; Kornelisse RF; van Weissenbruch M; Baerts W; Liem KD; van Bel F; Heijnen CJ
Psychoneuroendocrinology; 2013 Jul; 38(7):975-86. PubMed ID: 23107421
[TBL] [Abstract][Full Text] [Related]
36. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age.
O'Shea TM; Kothadia JM; Klinepeter KL; Goldstein DJ; Jackson BG; Weaver RG; Dillard RG
Pediatrics; 1999 Jul; 104(1 Pt 1):15-21. PubMed ID: 10390254
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone.
Weiler HA; Paes B; Shah JK; Atkinson SA
Early Hum Dev; 1997 Feb; 47(3):271-86. PubMed ID: 9088794
[TBL] [Abstract][Full Text] [Related]
38. Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone.
Karemaker R; Heijnen CJ; Veen S; Baerts W; Samsom J; Visser GH; Kavelaars A; van Doornen LJ; van Bel F
Pediatr Res; 2006 Dec; 60(6):745-50. PubMed ID: 17065571
[TBL] [Abstract][Full Text] [Related]
39. Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial.
Romagnoli C; Zecca E; Vento G; Maggio L; Papacci P; Tortorolo G
Pharmacology; 1999 Nov; 59(5):266-74. PubMed ID: 10529659
[TBL] [Abstract][Full Text] [Related]
40. Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years.
Salokorpi T; Sajaniemi N; Hällback H; Kari A; Rita H; von Wendt L
Acta Paediatr; 1997 Mar; 86(3):294-8. PubMed ID: 9099320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
